Balaxi Pharmaceuticals Ltd.
Snapshot View

499.90 -0.35 ▼-0.1%

08 February 2023, 09:07:56 AM
Volume: 5

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.balaxipharma.in
Market Cap 501.48 Cr.
Enterprise Value(EV) 503.74 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 50.45 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 9.92 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 151.76 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.30 Calculated using Price: 500.25
Dividend Yield 0.10 Period Ending 2022-03
No. of Shares Subscribed 1.00 Cr. 10,024,500 Shares
FaceValue 10
Company Profile
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.07%
1 Week
-5.96%
1 Month
-15.94%
3 Month
-20.13%
6 Month
+16.69%
1 Year
+6.45%
2 Year
-15.36%
5 Year
+3266.33%
10 Year
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 55.84 39.04 82.26 53.50
Return on Capital Employed (%) 69.35 56.56 92.56 59.62
Return on Assets (%) 32.19 29.01 56.23 34.52

Balance Sheet View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 28 65 113 149
Non Curr. Liab. 0 0 1
Curr. Liab. 3 8 35 63 50
Minority Int.
Equity & Liab. 6 36 100 176 199
Non Curr. Assets 0 1 6 35 45
Curr. Assets 6 35 94 141 155
Misc. Exp. not W/O
Total Assets 6 36 100 176 199

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 14 46 231 279 345
Other Income 1 1 2 5 7
Total Income 14 46 234 284 352
Total Expenditure -12 -37 -189 -229 -290
PBIDT 2 9 45 56 62
Interest 0 0 -1 0
Depreciation 0 0 -1 -1
Taxation 0 -3 -6 -7 -10
Exceptional Items
PAT 2 6 38 48 51
Minority Interest
Share Associate
Other Related Items -1 1
Consolidated Net Profit 2 6 37 48 51
Adjusted EPS 6 6 37 48 51

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 -14 34
Cash Fr. Inv. 0 0 -6 -28
Cash Fr. Finan. 18 4 0
Net Change -2 4 -2 6
Cash & Cash Eqvt 0 4 2 7

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 72.86 72.86 72.86 72.86 72.86 72.86 72.86 72.86 72.69
Public 27.13 27.14 27.14 27.13 27.14 27.14 27.14 27.14 27.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 07 Feb 2023
Copy of Newspaper Publication
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication
Tue, 07 Feb 2023
Shareholders meeting
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Postal Ballot
Mon, 06 Feb 2023
Shareholders meeting
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Postal Ballot

Technical Scans View Details >>

Tue, 07 Feb 2023
Close Crossing Last Month Low Close Crossing Last Month Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 5 Years High Increase in 5 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,004.80 -0.2%
Cipla Ltd. 83,244.79 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,450.00 +0.2%
Divi's Laboratories Ltd. 72,982.62 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. 51,953.07 1,536.10 0.0%
Zydus Lifesciences Ltd. 48,525.07 480.15 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-12 31.56 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 480.15 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-12 3.67 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 480.15 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.15 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.15 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.15 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.15 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.15 +0.2%

FAQ's On Balaxi Pharmaceuticals Ltd.

What is Balaxi Pharma. share price?

Can I buy Balaxi Pharma. shares now?

What is the Dividend Yield of Balaxi Pharma.?

What is the Market Cap of Balaxi Pharma.?

What are the key metrics to analyse Balaxi Pharma.?

What is the 52 Week High and Low of Balaxi Pharma.?

What is the trend of Balaxi Pharma. share price?